Fig. 4From: Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in ChinaUnadjusted and adjusted risks of MACE between patients with PDC ≥ 0.5 and PDC < 0.5 in primary (N = 34,372) and secondary (N = 65,283) prevention subgroupsBack to article page